Clustering data with hclust algorithm for Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver (Study ST000915)
Core K Prenols/Cardiolipins (Analysis AN001487)| Metabolite | Structure | F1 | F2 | F3 | F4 |
|---|---|---|---|---|---|
| Dolichol-20 | ME231044 | 0.38 | 1.02 | 1.29 | 1.18 |
| Dolichol-19 | ME231043 | 0.46 | 1.00 | 1.29 | 1.13 |
| Dolichol-17 | ME231041 | 0.50 | 0.98 | 1.29 | 1.10 |
| Dolichol-18 | ME231042 | 0.54 | 0.97 | 1.27 | 1.10 |
| CL (74:8) | ME231039 | 0.67 | 1.07 | 1.18 | 0.97 |
| CL (72:8) | ME231038 | 0.69 | 1.00 | 1.12 | 1.16 |
| CL (74:7) | ME231040 | 0.58 | 1.05 | 1.18 | 1.10 |
| CoQ-10 | ME231046 | 1.12 | 0.80 | 1.14 | 0.84 |
| CL (70:7) | ME231037 | 0.95 | 1.08 | 1.04 | 0.91 |
| CoQ-9 | ME231045 | 1.01 | 1.06 | 1.06 | 0.81 |
Factors:
| F1 | Diagnosis:Cirrhosis |
| F2 | Diagnosis:NASH |
| F3 | Diagnosis:Normal |
| F4 | Diagnosis:Steatosis |
